Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Operating Expenses | 27,262 | 27,233 | 4,219 | 120 |
| Operating Income | -27,262 | -27,233 | -4,219 | -120 |
| Other Income | 132 | 94 | 6 | 0 |
| Pre-tax Income | -27,130 | -27,139 | -4,213 | -120 |
| Net Income Continuous | -27,130 | -27,139 | -4,213 | -120 |
| Net Income | $-27,130 | $-27,139 | $-4,213 | $-120 |
| EPS Basic Total Ops | -1.37 | -1.44 | -1.13 | -0.06 |
| EPS Basic Continuous Ops | -1.37 | -1.44 | -1.13 | -0.06 |
| EPS Diluted Total Ops | -1.37 | -1.44 | -1.13 | -0.06 |
| EPS Diluted Continuous Ops | -1.37 | -1.44 | -1.13 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -1.37 | N/A | N/A | N/A |
| EBITDA(a) | $-26,888 | $-27,088 | $-4,216 | $-120 |